Newly Approved Drug Therapies (425): DDAVP (tablet formulation), Rhone Poulenc Rorer

Description of Medical Areas

About the FDA Approved Listings

Drugs Approved by the FDA

Drug Name: DDAVP (tablet formulation)

The following information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Company: Rhone Poulenc Rorer
Approval Status: Approved March 1998
Treatment for: nocturnal enuresis

General Information

A tablet formulation of DDAVP (desmopressin acetate) has been approved for managing primary nocturnal enuresis in patients age six and over. DDAVP is a synthetic form of vasopressin that has been available in nasal spray since 1989. Vasopressin regulates water balance and urine production.

Back to Drug Listing

Drug listing last updated on June 20, 2008

Patient Resources: [ Trial Listing ] [ Notification Services ] [ Drug Directories ]
[ About Clinical Research ] [ Patient Resources ] [ Patient Bookstore ]
Professional Resources: [ Research Center Profiles ] [ Industry Provider Profiles ] [ Jobs in Clinical Research ]
[ Industry News ] [ Professional Resources ] [ Professional Bookstore ]
General: [ Search ] [ Site Map ] [ Your Privacy ] [ CW World ] [ Home ]